Clinical Trial Update: A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer [Phase 1]

View source ↗

Summary

Eli Lilly is conducting a Phase 1 study of the PET radiotracer [18F]LY4214835 in healthy volunteers and cancer patients, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• [18F]LY4214835 (LY4214835)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Neoplasms, Healthy | Phase 1 | Status: RECRUITING